D. E. Shaw & Co., Inc. - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 278 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2021. The put-call ratio across all filers is 1.50 and the average weighting 0.2%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2023$1,071,594
+12.0%
21,338
+0.3%
0.00%0.0%
Q1 2023$956,937
-44.5%
21,270
-46.0%
0.00%
-50.0%
Q4 2022$1,724,186
-17.1%
39,356
+24.7%
0.00%0.0%
Q3 2022$2,079,000
+8.7%
31,549
-16.6%
0.00%0.0%
Q2 2022$1,912,000
-41.7%
37,847
-26.3%
0.00%
-33.3%
Q1 2022$3,281,000
-83.0%
51,369
-71.4%
0.00%
-81.2%
Q4 2021$19,255,000
-9.6%
179,767
-13.2%
0.02%
-15.8%
Q3 2021$21,297,000
-10.7%
207,149
-23.6%
0.02%
-9.5%
Q2 2021$23,846,000
-4.8%
271,097
+5.2%
0.02%
-12.5%
Q1 2021$25,060,000
-19.5%
257,742
-7.2%
0.02%
-14.3%
Q4 2020$31,137,000
+11.6%
277,634
-7.8%
0.03%
-3.4%
Q3 2020$27,910,000
+833.8%
301,088
+685.7%
0.03%
+625.0%
Q2 2020$2,989,000
-64.7%
38,319
-73.5%
0.00%
-69.2%
Q1 2020$8,467,000
-33.2%
144,781
-8.5%
0.01%
-7.1%
Q4 2019$12,679,000
+55.6%
158,270
+42.7%
0.01%
+40.0%
Q3 2019$8,150,000
-63.9%
110,931
-53.7%
0.01%
-64.3%
Q2 2019$22,586,000
+216.8%
239,433
+168.8%
0.03%
+211.1%
Q1 2019$7,130,000
+181.6%
89,068
+222.6%
0.01%
+200.0%
Q1 2018$2,532,000
+136.9%
27,613
-27.5%
0.00%
+50.0%
Q4 2016$1,069,000
+55.4%
38,097
+64.5%
0.00%
+100.0%
Q3 2016$688,000
-24.1%
23,155
-32.3%
0.00%0.0%
Q2 2015$906,00034,1910.00%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q2 2021
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 645,539$69,144,0007.84%
DAFNA Capital Management LLC 206,911$22,162,0005.57%
Eagle Health Investments LP 192,639$20,634,0005.03%
Casdin Capital, LLC 1,550,000$166,021,0004.68%
CADIAN CAPITAL MANAGEMENT, LP 450,657$48,270,0002.65%
Avidity Partners Management LP 995,000$106,574,0002.26%
Integral Health Asset Management, LLC 75,000$8,033,0002.22%
Rock Springs Capital Management LP 859,755$92,088,0002.13%
Boxer Capital, LLC 507,374$54,345,0002.11%
EFG Asset Management (North America) Corp. 112,715$12,082,0001.58%
View complete list of BLUEPRINT MEDICINES CORP shareholders